Clinical Trials Logo
  1. Home
  2. Substance Use Disorders
  3. NCT03118011
  4. Details
NCT03118011 Clinical Trial

Substance Use Disorders and Tobacco Habits

Substance Use Disorders Clinical Trial

Official title:
Tobacco Habits and the Ability to Quit Smoking Among Patients With Substance Use Disorders

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03118011
Other study ID # 2017/048
Secondary ID
Status Recruiting
Phase N/A
First received April 10, 2017
Last updated April 12, 2017
Start date April 10, 2017
Est. completion date December 2018

Study information
Verified date April 2017
Source Uppsala University
Contact Katarina Danielsson, MD, PhD
Phone 0046186112173
Email katarina.danielsson@akademiska.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In the department for substance use disorders at Uppsala University Hospital there are two wards. One that is locked, where the patients that are emitted can not go out to smoke and another ward where there is a possibility to go out and smoke during the day.

The smoking habits on those two floors will be compared and how they feel about smoking will be evaluated when they are admitted to the ward, at discharge, after 1 mont and after 6 months.

Description:

In the department for substance use disorders at Uppsala University Hospital there are two wards. One that is locked, where the patients that are emitted can not go out to smoke and another ward where there is a possibility to go out and smoke during the day.

The smoking habits on those two wards will be compared and how they feel about smoking will be evaluated when they are admitted to the ward, at discharge, after 1 mont and after 6 months.

The questionnaires that will be used for evaluation are:

Fagerstöms test for nicotine dependence, Alcohol Use Disorders Identification Test and Drug Use Disorders Identification Test and the symptoms of Tobacco withdrawal mentioned in DSM-V.

Parameters that will be measured are: pulse, bloodpressure, peak expiratory flow, wight and height.

There will also be some questions about their smoking and snuff habits, if they have tried to quite smoking Before and how they were affected by the stop.

Recruitment information / eligibility
Status Recruiting
Enrollment 200
Est. completion date December 2018
Est. primary completion date October 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: Substance use disorder -

Exclusion Criteria: Disorganization, psychosis and if you can not speak Swedish.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• No smoking
No smoking
• Smoking
Ability to go out to smoke

Locations
Country Name City State
Sweden Uppsala University Hospital Uppsala

Sponsors (1)
Lead Sponsor Collaborator
Uppsala University

Country where clinical trial is conducted

Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary Less smoking Number of cigarettes /day From baseline to 1 month
Primary Less smoking Number of cigarettes /day From baseline to 6 month
Secondary withdrawal symptoms Blood pressure, Worry, nausea e.t.c. From baseline to emitted from the ward aproximately 1 week
Secondary withdrawal symptoms Blood pressure, Worry, nausea e.t.c. From baseline to 1 month
Secondary withdrawal symptoms Blood pressure, Worry, nausea e.t.c. From baseline to 6 month
Secondary Thought about not smoking any more Questions From baseline to emitted from the ward aproximately 1 week
Secondary Thought about not smoking any more Questions From baseline to 1 month
Secondary Thought about not smoking any more Questions From baseline to 6 month
Secondary PEF Improved expiratory flow From baseline to emitted from the ward aproximately 1 week
Secondary PEF Improved expiratory flow From baseline too 1 month
Secondary PEF Improved expiratory flow From baseline to 6 month
Secondary Weight Changes in weight From baseline to emitted from the ward aproximately 1 week
Secondary Weight Changes in weight From baseline to 1 month
Secondary Weight Changes in weight From baseline to 6 month
See also
  Status Clinical Trial Phase
Completed NCT05660434 - Using Aromatherapy in Substance Use Disorder N/A
Active, not recruiting NCT05338268 - Substance Use and Loneliness N/A
Completed NCT03954184 - E-health Implementation (Iowa) N/A
Completed NCT04098614 - Barriers to Substance Use Disorder Recovery N/A
Completed NCT03590106 - Cardiac Surgery Peer Recovery Support Program N/A
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Recruiting NCT05327504 - Written Exposure Therapy for Veterans With SUD and PTSD N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04401215 - Technologically-Augmented Referrals to Mitigate Addiction Consequences N/A
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Not yet recruiting NCT06187701 - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Active, not recruiting NCT02382042 - Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans N/A
Terminated NCT01356667 - Drum-Assisted Therapy for Native Americans N/A
Completed NCT01237366 - Study Targeting Affect Regulation Phase 1/Phase 2
Completed NCT00708890 - Twelve Step Based Self-help Groups for Substance Related Disorders N/A
Active, not recruiting NCT04048850 - Zepatier in Patients With Substance Use
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2